- Mercredi 16 décembre 2026 de 9h à 16h15 et jeudi 17 décembre 2026 de 9h à 16h
- SWISS Foundation for Innovation and Training in Surgery (SFITS), Rue Gabrielle-Perret-Gentil 4, 1205 Geneva
- Conférence en anglais
- Sur inscription à l'adresse suivante : Catherine.Cretton@hug.ch
Cette formation a pour but le partage d’expériences sur le traitement du cancer de la prostate entre deux pays et deux cultures différentes.
Informations pratiques
Programme
Module 1 - Mercredi 16 décembre
09:00-10:15 : part 1
Moderators: Dr Bülent Karabulut, President of TTOD, medical oncologist of Acibadem Kent and Pr Alfredo Addeo, M.D., head of Medical oncology division, HUG
- 09:00-09:15 Opening session
Dr. Bülent Karabulut
Pr. Alfredo Addeo, M.D., head of Medical oncology division, HUG - 09:15-09:45 The role of active surveillance
Dr D. Benamran, staff physician, Urology division, HUG - 09:45-10:15 PET PSMA in prostate cancer
Pre Valentina Garibotto, M.D., head of Nuclear medicine division, HUG - 10:15-10:30 Coffee Break
10:30-12:00 :part 2
Moderators : Pr. Dr. Mustafa Erman, Medical oncologist at Hacettepe University Hospital and Dr D. Benamran, Urology division, HUG
- 10:30-11:00 Prostatectomy in localized prostate cancer
Pr Massimo Valerio, M.D., head of Urology division and Prostate centre, HUG - 11:00-11:30 Radiotherapy in localized prostate cancer
Pr M. Shelan, Radiation oncologist, Bern - 11:30-12:00 New paradigms and future directions in metastatic prostate cancer treatment
Dr Petros Tsantoulis, staff physician, Medical oncology division, HUG - 12:00-13:00 Lunch Break
13:00-14:30 : part 3
Moderator: Pr Dr Deniz Tural, Medical oncologist at Koç University Hospital
- 13:00-13:30 The role of RMN in localized and metastatic prostate cancer
Dr Thomas De Perrot, radiologist, Prostate centre, HUG - 13:00-14:30
- mHSPC Low volume: multidisciplinary approach
Dr Dominik Berthold, oncologist, head of Prostate ceentre, CHUV - mHSPC – High volume: Defining the standard of care
Dr Emre Yekedüz, Medical oncologist at Ankara University Hospital
- mHSPC Low volume: multidisciplinary approach
- 14:30-14:45 Coffee Break
14:45-16:15 : part 4
Moderator: Dr Petros Tsantoulis, staff physician, Medical oncology division, HUG and Dr Gökşen İnanç İmamoğlu, Medical oncologist at Ankara City Hospital
- 14:45-15:15 ARPIs in prostate cancer: patient selection and personalized treatment
Dr Gökşen İnanç İmamoğlu, Medical oncologist at Ankara City Hospital - 15:15-16:15 Clinical scenarios and discussion
Dr Maxime Borgeaud, M.D., senior resident, Medical oncology division, HUG
Module 2 – jeudi 17 décembre
09:00-10:30 : part 1
Moderator: Dr Mustafa Erman, Medical oncologist at Hacettepe University Hospital
- 09:00-09:30 Radioligand therapy in prostate cancer: new standards & future directions
Dr Nicola Bianchetto M.D., Senior Resident, Nuclear medicine division, HUG) - 09:30-10:00 Castration-Resistant Prostate Cancer: Sequencing and Precision Treatment
Dr Petros Tsantoulis, staff physician, Medical oncology division, HUG - 10:00-10:30 RECIST and PCWG3 – clinical practice and trials
Dr Mustafa Erman, Medical oncologist at Hacettepe University Hospital - 10:30-10:45 Coffee Break
10:45-12:00 : part 2
Moderator: Dr Bülent Karabulut, President ot TTOD, Medical oncologist of Acibadem Kent Hospital
- 10:45-12:00 Clinical scenarios and discussion
Dr Maxime Borgeaud, M.D., senior resident, Medical oncology division, HUG - 12:00-13:00 Lunch Break
- 13:00-16:00 TTOD Session-Insights and Reflections on Preceptorship
Moderator: Pr Dr Bülent Karabulut,
Speakers: Dr Mustafa Erman, Dr Deniz Tural, Dr Gökşen İnanç İmamoğlu, Dr Emre Yekedüz
Inscription
Places limitées.
Pour vous inscrire, merci d'adresser un email à :